FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3217327576> ?p ?o ?g. }

• W3217327576 endingPage "e0260469" @default.
• W3217327576 startingPage "e0260469" @default.
• W3217327576 abstract "To evaluate changes in choroidal vascular structure and aqueous cytokine levels in eyes with vitreoretinal lymphoma (VRL) after intravitreal methotrexate (MTX) treatment.In this retrospective study, VRL patients who visited our hospital between October 2018 and July 2020 were reviewed. Aqueous samples were obtained before treatment and at clinical resolution after intravitreal MTX therapy. Interleukin (IL)-6 and IL-10 levels and the IL-10-to-IL-6 ratio were evaluated. Swept-source optical coherence tomographic images were obtained along with the aqueous samples. Subfoveal choroidal thickness (SFCT), total vascular area of the choroid (TCA), stromal area (SA), luminal area (LA), and choroidal vascularity index (CVI) were assessed.Twelve patients were enrolled (female:male-5:7). The mean age (± standard deviation) at diagnosis was 60.9±8.5 years. In the 16 eyes diagnosed with VRL, values of SFCT, TCA, LA, and SA significantly decreased after treatment (all p-values <0.05). Additionally, the aqueous cytokine IL-10 level and IL-10-to-IL-6 ratio were significantly decreased (p = 0.001 and p = 0.003, respectively). The choroidal structure in the non-treated fellow eyes did not show any significant difference. There were no further changes in SFCT, TCA, LA, or CVI that occurred during maintenance therapy. For clinical remission, the patients received 7.7±5.5 intravitreal MTX injections. The required number of injections for clinical remission was positively correlated with best-corrected visual acuity, IL-10, and IL-6 levels in the active phase (p = 0.035, p = 0.009, and p = 0.031, respectively).Eyes with active VRL exhibited choroidal thickening with increased vascular and stromal areas that decreased after remission following MTX treatment. Higher aqueous IL-10 and IL-6 levels and lower visual acuity in the active phase may indicate the number of injections required for remission; this should be considered in the treatment of patients with VRL." @default.
• W3217327576 created "2021-12-06" @default.
• W3217327576 creator A5010131318 @default.
• W3217327576 creator A5032209991 @default.
• W3217327576 creator A5069563388 @default.
• W3217327576 creator A5083283257 @default.
• W3217327576 creator A5090878041 @default.
• W3217327576 creator A5091623479 @default.
• W3217327576 date "2021-11-23" @default.
• W3217327576 modified "2023-09-24" @default.
• W3217327576 title "Changes in choroidal vascular structure from vitreoretinal lymphoma and the intraocular cytokine level associated with clinical resolution after intravitreal methotrexate treatment" @default.
• W3217327576 cites W1837179522 @default.
• W3217327576 cites W1972005608 @default.
• W3217327576 cites W1973463377 @default.
• W3217327576 cites W1982977010 @default.
• W3217327576 cites W1983979831 @default.
• W3217327576 cites W1987330967 @default.
• W3217327576 cites W2020779550 @default.
• W3217327576 cites W2031913474 @default.
• W3217327576 cites W2036368820 @default.
• W3217327576 cites W2039418236 @default.
• W3217327576 cites W2046455257 @default.
• W3217327576 cites W2051362212 @default.
• W3217327576 cites W2064043899 @default.
• W3217327576 cites W2078950541 @default.
• W3217327576 cites W2084816571 @default.
• W3217327576 cites W2094418620 @default.
• W3217327576 cites W2115919961 @default.
• W3217327576 cites W2149603266 @default.
• W3217327576 cites W2310716991 @default.
• W3217327576 cites W2321112839 @default.
• W3217327576 cites W2346487820 @default.
• W3217327576 cites W2409743699 @default.
• W3217327576 cites W2414720150 @default.
• W3217327576 cites W2481599592 @default.
• W3217327576 cites W2519674788 @default.
• W3217327576 cites W2753787583 @default.
• W3217327576 cites W2767963203 @default.
• W3217327576 cites W2781535245 @default.
• W3217327576 cites W2895597919 @default.
• W3217327576 cites W2911236219 @default.
• W3217327576 cites W2966924933 @default.
• W3217327576 cites W2972323035 @default.
• W3217327576 cites W3003859761 @default.
• W3217327576 cites W3005408046 @default.
• W3217327576 cites W3089288148 @default.
• W3217327576 cites W3091340845 @default.
• W3217327576 cites W72812651 @default.
• W3217327576 doi "https://doi.org/10.1371/journal.pone.0260469" @default.
• W3217327576 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8610271" @default.
• W3217327576 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34813633" @default.
• W3217327576 hasPublicationYear "2021" @default.
• W3217327576 type Work @default.
• W3217327576 sameAs 3217327576 @default.
• W3217327576 citedByCount "0" @default.
• W3217327576 crossrefType "journal-article" @default.
• W3217327576 hasAuthorship W3217327576A5010131318 @default.
• W3217327576 hasAuthorship W3217327576A5032209991 @default.
• W3217327576 hasAuthorship W3217327576A5069563388 @default.
• W3217327576 hasAuthorship W3217327576A5083283257 @default.
• W3217327576 hasAuthorship W3217327576A5090878041 @default.
• W3217327576 hasAuthorship W3217327576A5091623479 @default.
• W3217327576 hasBestOaLocation W32173275761 @default.
• W3217327576 hasConcept C118487528 @default.
• W3217327576 hasConcept C120665830 @default.
• W3217327576 hasConcept C121332964 @default.
• W3217327576 hasConcept C126322002 @default.
• W3217327576 hasConcept C2776694393 @default.
• W3217327576 hasConcept C2777093970 @default.
• W3217327576 hasConcept C2778257484 @default.
• W3217327576 hasConcept C2781059491 @default.
• W3217327576 hasConcept C71924100 @default.
• W3217327576 hasConceptScore W3217327576C118487528 @default.
• W3217327576 hasConceptScore W3217327576C120665830 @default.
• W3217327576 hasConceptScore W3217327576C121332964 @default.
• W3217327576 hasConceptScore W3217327576C126322002 @default.
• W3217327576 hasConceptScore W3217327576C2776694393 @default.
• W3217327576 hasConceptScore W3217327576C2777093970 @default.
• W3217327576 hasConceptScore W3217327576C2778257484 @default.
• W3217327576 hasConceptScore W3217327576C2781059491 @default.
• W3217327576 hasConceptScore W3217327576C71924100 @default.
• W3217327576 hasFunder F4320322120 @default.
• W3217327576 hasIssue "11" @default.
• W3217327576 hasLocation W32173275761 @default.
• W3217327576 hasLocation W32173275762 @default.
• W3217327576 hasLocation W32173275763 @default.
• W3217327576 hasLocation W32173275764 @default.
• W3217327576 hasOpenAccess W3217327576 @default.
• W3217327576 hasPrimaryLocation W32173275761 @default.
• W3217327576 hasRelatedWork W1493696185 @default.
• W3217327576 hasRelatedWork W1522459299 @default.
• W3217327576 hasRelatedWork W1984566269 @default.
• W3217327576 hasRelatedWork W2028156947 @default.
• W3217327576 hasRelatedWork W2066518120 @default.
• W3217327576 hasRelatedWork W2071219047 @default.
• W3217327576 hasRelatedWork W2516167102 @default.
• W3217327576 hasRelatedWork W3087139773 @default.
• W3217327576 hasRelatedWork W3216719612 @default.

• next